Marco Oderda

1 clinical trials · Sponsor

Record	Firm	Date
Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET (NCT06758882)	Marco Oderda	2024-11-25

Every clearance here is in the API, with alerts when new ones post.